PlainRecalls
FDA Drug Low Class III Terminated

Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42

Reported: February 9, 2022 Initiated: January 7, 2022 #D-0522-2022

Product Description

Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42

Reason for Recall

Mislabeling

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
6430 cartons
Distribution
USA Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42. Recalled by Teva Pharmaceuticals USA. Units affected: 6430 cartons.
Why was this product recalled?
Mislabeling
Which agency issued this recall?
This recall was issued by the FDA Drug on February 9, 2022. Severity: Low. Recall number: D-0522-2022.